Want to see MIR full AI Analyst Report?
MIR Stock Chart & Stats
$19.72
-$0.41(-2.41%)
At close: 4:00 PM EST
$19.72
-$0.41(-2.41%)
Day’s Range― - ―
52-Week Range$15.57 - $30.28
Previous CloseN/A
Volume292.68K
Average Volume (3M)3.88M
Market Cap
$4.08B
Enterprise Value$5.42K
Total Cash (Recent Filing)$404.90M
Total Debt (Recent Filing)$1.23B
Price to Earnings (P/E)153.8
Beta1.55
Next Earnings
Jul 28, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.11
Shares Outstanding244,655,720
10 Day Avg. Volume3,501,878
30 Day Avg. Volume3,876,376
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)2.89
Price to Sales (P/S)5.82
P/FCF Ratio50.38
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$27.00Price Target Upside36.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.54
Revenue Forecast (FY)$1.14B
Bulls Say, Bears Say
Bulls Say
Backlog And Order MomentumA $1.1B backlog and large order growth provide multi-quarter revenue visibility and support durable top-line stability. This backlog underpins recurring service and project work, reducing near-term demand cyclicality and enabling predictable execution and revenue recognition over coming quarters.
Exposure To Nuclear, SMR And Medical End MarketsMarket exposure to nuclear power, emerging SMR demand, and recovering medical RTQA creates structural tailwinds. These regulated, compliance-driven end markets generate repeat purchases, long service lifecycles, and higher switching costs, supporting recurring revenue and long-term demand resilience.
Improved Profitability And Strong Gross MarginsA return to positive net income with mid-to-high 40% gross margins and >20% adjusted EBITDA indicates durable operational leverage in core products and services. Sustained margins support reinvestment, R&D and integration of acquisitions while underpinning longer-term earnings improvement.
Bears Say
Near-term Margin Dilution From Recent M&AAcquisitions (notably Paragon) have expanded scale but compressed consolidated margins short term, creating integration and margin-recovery risk. Management expects eventual accretion, but near-term margin dilution could delay achieving the company’s 30%+ EBITDA target and pressure free cash flow conversion.
Weak Cash Conversion & Lumpy Project Cash FlowsCash generation has improved vs earlier years but remains uneven: FCF declined TTM and operating cash covers a small fraction of accounting earnings. Lumpy project receipts and working-capital timing can strain liquidity, constrain optionality for buybacks or bolt-on deals, and increase refinancing sensitivity.
Rising Leverage And Modest Returns On EquityAlthough leverage is still moderate, the step-up in debt alongside only low single-digit ROE limits financial flexibility. Higher leverage reduces the buffer for cyclical shocks, and modest returns signal the company must improve capital efficiency to justify ongoing investment and meet long-term return targets.
Mirion Technologies News
MIR FAQ
What was Mirion Technologies, Inc.’s price range in the past 12 months?
Mirion Technologies, Inc. lowest stock price was $15.57 and its highest was $30.28 in the past 12 months.
What is Mirion Technologies, Inc.’s market cap?
Mirion Technologies, Inc.’s market cap is $4.08B.
When is Mirion Technologies, Inc.’s upcoming earnings report date?
Mirion Technologies, Inc.’s upcoming earnings report date is Jul 28, 2026 which is in 5 days.
How were Mirion Technologies, Inc.’s earnings last quarter?
Mirion Technologies, Inc. released its earnings results on Apr 28, 2026. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of $0.095 by $0.005.
Is Mirion Technologies, Inc. overvalued?
According to Wall Street analysts Mirion Technologies, Inc.’s price is currently Undervalued.
Does Mirion Technologies, Inc. pay dividends?
Mirion Technologies, Inc. does not currently pay dividends.
What is Mirion Technologies, Inc.’s EPS estimate?
Mirion Technologies, Inc.’s EPS estimate is 0.1.
How many shares outstanding does Mirion Technologies, Inc. have?
Mirion Technologies, Inc. has 244,655,720 shares outstanding.
What happened to Mirion Technologies, Inc.’s price movement after its last earnings report?
Mirion Technologies, Inc. reported an EPS of $0.1 in its last earnings report, beating expectations of $0.095. Following the earnings report the stock price went down -0.107%.
Which hedge fund is a major shareholder of Mirion Technologies, Inc.?
Currently, no hedge funds are holding shares in MIR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Mirion Technologies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$27.00 (36.92% Upside)
$27.00 (36.92% Upside)
Blogger Sentiment
Bullish
MIR Sentiment 70%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Decreased
By 58.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $165.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 3.4%
Last 30 Days ▼ 3.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.95%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
34.67%
Trailing 12-Months
Company Description
Mirion Technologies, Inc.
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
MIR Stock 12 Month Forecast
Average Price Target
$27.00
▲(36.92% Upside)
Technical Analysis
Ownership Overview
4.44% Insiders
32.61% Mutual Funds
3.41% Other Institutional Investors
29.86% Public Companies and
Individual Investors







